IDENTIFICATION AND ANALYSIS OF GENETIC MARKERS ASSOCIATED WITH TYPE 1 DIABETES IN THE PEDIATRIC POPULATION

A  IBRAR; MSU REHMAN; H HABIB

doi:10.54112/bcsrj.v2024i1.1007

Authors

A IBRAR Allied/DHQ Hospital Faisalabad, Pakistan
MSU REHMAN Allied/DHQ Hospital Faisalabad, Pakistan
H HABIB Allied/DHQ Hospital Faisalabad, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2024i1.1007

Keywords:

Autoimmune, Genetic Markers, Genome-Wide Association Study, Pediatrics, Personalized Medicine, Type 1 Diabetes, Immune Regulation

Abstract

Type 1 diabetes (T1D) is a chronic autoimmune disorder primarily affecting children and adolescents, characterized by the destruction of insulin-producing beta cells. Genetic factors are crucial in T1D susceptibility, yet the complete genetic underpinnings remain partially understood. Identifying genetic markers associated with T1D can enhance our understanding of its pathogenesis and facilitate the development of predictive tools and personalized therapies. Objective: To identify and analyze genetic markers associated with type 1 diabetes in pediatric populations to improve understanding of diagnosis and targeted therapeutic interventions. Methods: This case-control study in Allied Hospital Faisalabad from August 2023 to April 2024 involved 150 pediatric T1D patients and 150 age-matched healthy controls. Genomic DNA was extracted and analyzed using genome-wide association studies (GWAS) with high-density SNP arrays. Significant SNPs were identified through logistic regression, adjusting for potential confounders. Functional annotation and pathway enrichment analyses were performed. Validation was achieved by replicating an independent cohort of 200 T1D patients and 200 controls. Results: Fifteen SNPs reached genome-wide significance (p < 5 x 10^-8), with the strongest association at rs9273363 (OR = 3.2, 95% CI: 2.4-4.2, p = 1.2 x 10^-10). Other notable SNPs included rs2476601 (OR = 2.5, 95% CI: 1.9-3.3, p = 4.5 x 10^-8) and rs689 (OR = 2.0, 95% CI: 1.5-2.7, p = 7.1 x 10^-7). Pathway analysis highlighted the significant involvement of immune-related pathways. Replication confirmed these associations with consistent effect sizes and significance levels. Conclusion: This study identified multiple genetic markers associated with T1D in pediatric populations, particularly in the HLA, PTPN22, and INS regions. These findings enhance the understanding of T1D genetics and underscore the importance of immune regulation. The identified markers hold the potential for predictive tools and personalized therapeutic strategies, paving the way for precision medicine in T1D management.

Downloads

Download data is not yet available.

References

Haller MJ, Atkinson MA, Schatz DJPC. Type 1 diabetes mellitus: etiology, presentation, and management. 2005;52(6):1553-78.

Simmons KM, Michels AWJWjod. Type 1 diabetes: A predictable disease. 2015;6(3):380.

Crux NB, Elahi SJFii. Human leukocyte antigen (HLA) and immune regulation: how do classical and non-classical HLA alleles modulate immune response to human immunodeficiency virus and hepatitis C virus infections? 2017;8:832.

Kenney AD, Dowdle JA, Bozzacco L, McMichael TM, St. Gelais C, Panfil AR, et al. Human genetic determinants of viral diseases. 2017;51(1):241-63.

Arleevskaya M, Takha E, Petrov S, Kazarian G, Renaudineau Y, Brooks W, et al. Interplay of environmental, individual and genetic factors in rheumatoid arthritis provocation. 2022;23(15):8140.

Akil AA-S, Yassin E, Al-Maraghi A, Aliyev E, Al-Malki K, Fakhro KAJJotm. Diagnosis and treatment of type 1 diabetes at the dawn of the personalized medicine era. 2021;19(1):137.

Michels A, Zhang L, Khadra A, Kushner JA, Redondo MJ, Pietropaolo MJPd. Prediction and prevention of type 1 diabetes: update on success of prediction and struggles at prevention. 2015;16(7):465-84.

Sayed S, Nabi ANJDfRtCPV. Diabetes and genetics: a relationship between genetic risk alleles, clinical phenotypes and therapeutic approaches. 2021:457-98.

Nasykhova YA, Barbitoff YA, Serebryakova EA, Katserov DS, Glotov ASJWjod. Recent advances and perspectives in next generation sequencing application to the genetic research of type 2 diabetes. 2019;10(7):376.

Abu Samra N, Jelinek HF, Alsafar H, Asghar F, Seoud M, Hussein SM, et al. Genomics and epigenomics of gestational diabetes mellitus: understanding the molecular pathways of the disease pathogenesis. 2022;23(7):3514.

Park YJJogm. Type 1 diabetes genetic susceptibility markers and their functional implications. 2014;11(1):1-10.

Chistiakov DA, Voronova NV, Chistiakova EIJCIR. Identification of new susceptibility genes for type 1 diabetes: An update. 2008;4(3):116-33.

Bergholdt RJDMB. Understanding type 1 diabetes genetics—approaches for identification of susceptibility genes in multi-factorial diseases. 2009;56:1-39.

Caliebe A, Tekola‐Ayele F, Darst BF, Wang X, Song YE, Gui J, et al. Including diverse and admixed populations in genetic epidemiology research. 2022;46(7):347-71.

Zhou H, Ye P, Xiong W, Duan X, Jing S, He Y, et al. Genome-scale CRISPR-Cas9 screening in stem cells: theories, applications and challenges. 2024;15(1):218.

Nurnberg ST, Zhang H, Hand NJ, Bauer RC, Saleheen D, Reilly MP, et al. From loci to biology: functional genomics of genome-wide association for coronary disease. 2016;118(4):586-606.

Anaya J-M, Duarte-Rey C, Sarmiento-Monroy JC, Bardey D, Castiblanco J, Rojas-Villarraga AJAR. Personalized medicine. Closing the gap between knowledge and clinical practice. 2016;15(8):833-42.

Chan IS, Ginsburg GSJArog, genetics h. Personalized medicine: progress and promise. 2011;12(1):217-44.

Jerram ST, Leslie RDJG. The genetic architecture of type 1 diabetes. 2017;8(8):209.

Kissler SJFiI. Genetic modifiers of thymic selection and central tolerance in type 1 diabetes. 2022;13:889856.

Sharp RC, Abdulrahim M, Naser ES, Naser SAJFic, microbiology i. Genetic variations of PTPN2 and PTPN22: role in the pathogenesis of type 1 diabetes and Crohn's disease. 2015;5:95.

Bottini N. Role of PTPN22 in type 1 diabetes. 2008.

Turkheimer E. Genome wide association studies of behavior are social science. Philosophy of behavioral biology: Springer; 2011. p. 43-64.

Uffelmann E, Huang QQ, Munung NS, De Vries J, Okada Y, Martin AR, et al. Genome-wide association studies. 2021;1(1):59.

Silberstein M, Nesbit N, Cai J, Lee PHJJog, genomics. Pathway analysis for genome-wide genetic variation data: Analytic principles, latest developments, and new opportunities. 2021;48(3):173-83.

Karchin RJBib. Next generation tools for the annotation of human SNPs. 2009;10(1):35-52.

Zhang X, Bai B, Wang T, Zhao J, Zhang N, Zhao Y, et al. PTPN22 interacts with EB1 to regulate T cell receptor signaling. 2018:481507.

Wojcik GL, Graff M, Nishimura KK, Tao R, Haessler J, Gignoux CR, et al. Genetic analyses of diverse populations improves discovery for complex traits. 2019;570(7762):514-8.

Curtsinger JM, Mescher MFJCoii. Inflammatory cytokines as a third signal for T cell activation. 2010;22(3):333-40.